영유아 영양 시장 : 시장 점유율 분석, 업계 동향 및 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the infant nutrition market size is projected to expand from USD 49.78 billion in 2025 and USD 52.48 billion in 2026 to USD 76.01 billion by 2031, registering a CAGR of 7.69% between 2026 to 2031.

This report is Segmented by Product Category (Infant Formula, Baby Cereals and More), Age Group (0-6 Months (Stage 1) and More), Formula Form (Powder, and More), Nature (Conventional, Organic, Clean Label/No Added Sugars & Additives), Distribution Channel (Supermarkets/Hypermarkets, and More), and Geography (North America and More). The Market Forecasts are Provided in Terms of Value (USD).

Global Infant Nutrition Market Trends and Insights

Rising Female Workforce Participation and Dual-Income Households Increasing Reliance On Formula and Convenient Complementary Foods

Women's labor-force engagement is high in many markets, while protections for paid leave and workplace breastfeeding support remain inconsistent, which raises daily-time constraints for caregivers and contributes to demand for formula and convenient complementary foods. In Mexico, value growth projections through the forecast horizon highlight the role of parents returning to workplaces and the appeal of ready-to-serve products for on-the-go feeding, which sustains category momentum within the infant nutrition market. In Canada, immigration-supported population gains and a preference for organic prepared foods have lifted demand for products aligned to dual-income lifestyles. Product innovation that reduces preparation time and simplifies portion control connects with working parents who seek reliable nutrition without additional household labor, an effect that has reinforced brand switching toward convenient formats in the infant nutrition market. The combined effect is a sustained mix shift toward higher-convenience products that carry a modest premium, which helps offset unit-volume pressure in mature markets.

Premiumization And Clean-Label or Organic Demand Expanding Value Growth

Parents are prioritizing verified quality signals and ingredient transparency, and new regulations are reinforcing this direction by codifying testing and disclosure practices. California's AB-899 requires heavy-metal testing disclosures for lead, arsenic, cadmium, and mercury, which has pushed brands to tighten raw material sourcing and reformulate to stay ahead of scrutiny. Major brands have responded with third-party certifications and portfolio cleanups, with Gerber citing more than 100 Clean Label Project certifications across its range, a position that builds trust among caregivers who associate seals and published standards with safety. New premium entries are anchoring position with dual certifications and staged formulations, as seen in Happy Family Organics' USDA and EU-certified European-made formula with a proprietary prebiotic and probiotic system, positioned at a premium price point to reflect its formulation and sourcing.Consumers across parts of Central and Eastern Europe show a willingness to import organic baby foods from other EU markets when local availability is limited, reinforcing how premiumization can be demand-led where safety and selection are perceived as stronger abroad. These behaviors expand value even if volumes are flat, which has become a central dynamic of the infant nutrition market.

Falling Birth Rates Limiting Volumes

Birth-rate declines in several large economies reduce the pool of new consumers, which creates persistent volume headwinds for the infant nutrition market. This demographic pattern is most acute in parts of East Asia and Southern Europe, where fertility rates remain low despite policy responses that aim to support families. Companies are adapting by expanding into adjacent life stages such as maternal nutrition and toddler milks, as well as exploring adult nutrition lines that extend household lifetime value. Premiumization helps offset the volume drag, since parents who remain in the category are trading up to products with validated science and quality labels. The net effect is a shift in growth mix toward value expansion and geographic diversification rather than broad-based volume gains.

Other drivers and restraints analyzed in the detailed report include:

1. Ingredient Science Innovation Enabling Premium Differentiation And Pricing Power
2. Omnichannel Expansion and Cross-Border E-Commerce Improving Access And Affordability
3. Stricter Marketing Rules Reduce Promotion

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Infant formula held 54.24% of 2025 value, while prepared baby food is projected to expand at a 9.12% CAGR through 2031, signaling a steady mix shift within the infant nutrition market. Formula remains entrenched as a breast-milk substitute in medically indicated use and among working caregivers who value predictability and time savings. The powder segment's cost-per-serving advantage sustains baseline demand even as the prepared category draws share on convenience features. In Canada, category trends show steady growth for prepared options where organic claims and texture variety align with modern feeding routines, reinforcing the pull toward convenience that is evident in the infant nutrition market. Fortified cereals continue to serve as a vehicle to address nutrient gaps during the 6-12 month window, and proposals to standardize iron levels in cereal would anchor consistent quality across brands.

Prepared foods stand out for portability, portion control, and flavor variety that ease the daily burden on dual-income households in the infant nutrition market. Packaging and labeling are part of the equation, with research documenting the increased use of health messaging and images of whole foods in retail promotions for infants and toddlers, which shapes perception even when claims are limited by policy. Specialty sub-segments such as goat-milk formula continue to widen caregiver choice, with clinical data indicating lower sensitivities for infants on goat-milk powder compared with cow-milk alternatives, a result that supports digestive-comfort positioning and targeted usage under pediatric guidance. The infant nutrition industry is therefore balancing the search for value with structural time constraints at home, which keeps both formula and ready-to-eat options central to category growth. Continued reformulation for contaminants compliance and steady progress on clean-label standards should sustain premium pricing in both pillars of the category.

The 0-6 months segment captured 39.41% of 2025 value and remains the anchor of demand due to exclusive feeding norms and higher clinical oversight, which concentrates prescription and recommendation influence in this window of the infant nutrition market share. Brands rely on Stage 1's clinical rigor to build credibility that flows into later stages, since many caregivers maintain loyalty after successful early experiences. The 6-12 months window marks the start of complementary feeding, and proposals to include specific micronutrients in infant cereals reflect regulators' focus on known deficiency risks during this period. The toddler segment stands out as a growth engine with an 8.34% projected CAGR, supported by functional claims that reassure parents about dietary adequacy as children shift to family foods. The infant nutrition market benefits when brands can translate early-stage trust into a lifecycle approach that aligns feeding to evolving nutrient needs.

Formulas for older infants and toddlers are leveraging ingredient science to tailor profiles to activity and cognitive development, with metabolomic work underscoring differences in amino acids and sugars across age stages. Branded solutions in Southeast Asia and other high-growth regions continue to emphasize microbiome and digestion benefits, as seen with new-stage launches across ASEAN in 2025, which reinforced the role of clinical features in capturing caregiver attention. In Japan, brand franchises that highlight decades of R&D and clinical validation maintain high awareness and professional endorsement, reinforcing parent confidence in stage-based formulas for children who are transitioning diets. The infant nutrition market will continue to rely on transparent stage definitions and trial-backed claims to stand out as choice expands.

Complete Report Scope:

• By Product Category
  • Infant Formula
  • Baby Cereals (Dried)
  • Prepared Baby Food
• By Age Group
  • 0-6 months (Stage 1)
  • 6-12 months (Stage 2)
  • 12-36 months (Toddler/Growing-up Milks & Foods)
• By Formula Form
  • Powder
  • Liquid Concentrate
  • Ready-to-Feed (RTF)
• By Nature
  • Conventional
  • Organic
  • Clean-label/No added sugars & additives
• By Distribution Channel
  • Supermarkets/Hypermarkets
  • Pharmacies/Medical Stores
  • Specialty Mom & Baby Stores
  • Online & Direct-to-Consumer
  • Convenience & Grocery Stores
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

Asia-Pacific accounts for 42.65% of 2025 value and is pacing global expansion at a 9.24% CAGR through 2030, which underscores the region's central role in demand formation for the infant nutrition market. Urbanization and rising incomes in large countries are reinforcing premium and clean-label preferences as caregivers balance work and family needs. Regulatory updates are guiding product formulations and permissible claims, as seen in Taiwan's draft rules on HMOs that would enable wider adoption of advanced ingredients across the early-childhood portfolio. Brand launches across ASEAN have emphasized microbiome and digestive support to stand out in crowded shelves, with stage-appropriate positioning aligned to local clinical practice. As cross-border platforms increase access to international formulas and baby foods, brands must manage Code compliance while meeting high expectations on ingredient transparency and testing. The infant nutrition market in Asia-Pacific remains the anchor of global value growth, with omnichannel ecosystems amplifying awareness and speeding adoption of new science-led features.

North America represents a mature but resilient demand base for the infant nutrition market, supported by population inflows and steady consumer interest in clean-label and organic products. Consolidation remains a feature of the region, where the top three players control a large share of retail value, and WIC contracting shapes competitive dynamics in formula across states. The policy environment retains a central role in supply stability and market entry, with enforcement discretion programs helping expand product access during tight supply periods while formal approvals progress, a pathway that enabled several brands to scale and build clinical programs. Lessons from recent disruptions prompted a system-wide focus on data visibility, quality assurance, and contingency planning, which has become a core expectation of retailers and agencies that serve families. Canada's regulatory modernization effort on infant foods and special dietary uses similarly signals a shift toward harmonized and evidence-based compositional standards that support both safety and innovation.

Europe remains a center of premium and organic adoption in the infant nutrition market, with layered certifications and strict compositional rules shaping portfolios. EU and USDA dual-certified offerings have grown in visibility, and parents in some Central and Eastern European markets are sourcing organic imports to access preferred choices and formats. National regulators continue to refine labeling and marketing oversight across age stages, and companies are steering investments toward clinical validation and nutritional science to strengthen differentiation. Established brands with long-standing pediatric endorsements maintain share through trust and rigorous quality controls, while new entrants use clean-label and gentle-on-the-gut narratives to gain footholds. Cross-border e-commerce within the EU supports product diversity and helps families access specific formulas and baby foods that are not always stocked locally. Over the medium term, premiumization and stage expansion will be the main levers to balance demographic pressures in parts of the region's consumer base.

1. Abbott Laboratories
2. Arla Foods amba
3. Beingmate Baby & Child
4. Bellamy's Organic
5. Bobbie
6. Bubs Australia
7. ByHeart
8. China Feihe Ltd.
9. Danone
10. H&H Group (Biostime)
11. Hero Group (Hero Baby)
12. HiPP GmbH & Co. Vertrieb KG
13. Holle baby food AG
14. Junlebao Dairy
15. Kendal Nutricare (Kendamil)
16. Kraft Heinz (Heinz Baby)
17. Meiji Holdings Co., Ltd.
18. Morinaga Milk Industry Co., Ltd.
19. Nestle S.A.
20. Reckitt
21. Royal FrieslandCampina N.V. (Friso)
22. Synutra International
23. Vinamilk (Dielac)

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Rising Female Workforce Participation and Dual-Income Households Increasing Reliance on Formula and Convenient Complementary Foods
  • 4.2.2 Premiumization and Clean-Label/Organic Demand Expanding Value Growth
  • 4.2.3 Ingredient Science Innovation Enabling Premium Differentiation and Pricing Power
  • 4.2.4 Omnichannel Expansion and Cross-Border E-Commerce Improving Access and Affordability
  • 4.2.5 Rising Goat/Alt-Milk & Hypoallergenic Options
  • 4.2.6 Specialty Medical Nutrition Gaining Adoption
• 4.3 Market Restraints
  • 4.3.1 Falling Birth Rates Limiting Volumes
  • 4.3.2 Stricter Marketing Rules Reduce Promotion
  • 4.3.3 Safety Issues/Recalls Hurting Trust
  • 4.3.4 Tougher Standards/Re-registration Increasing Costs
• 4.4 Value / Supply-Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technological Outlook
• 4.7 Porter's Five Forces Analysis
  • 4.7.1 Threat of New Entrants
  • 4.7.2 Bargaining Power of Suppliers
  • 4.7.3 Bargaining Power of Buyers
  • 4.7.4 Threat of Substitutes
  • 4.7.5 Intensity of Competitive Rivalry

5 Market Size & Growth Forecasts (Value in USD)

• 5.1 By Product Category
  • 5.1.1 Infant Formula
  • 5.1.2 Baby Cereals (Dried)
  • 5.1.3 Prepared Baby Food
• 5.2 By Age Group
  • 5.2.1 0-6 months (Stage 1)
  • 5.2.2 6-12 months (Stage 2)
  • 5.2.3 12-36 months (Toddler/Growing-up Milks & Foods)
• 5.3 By Formula Form
  • 5.3.1 Powder
  • 5.3.2 Liquid Concentrate
  • 5.3.3 Ready-to-Feed (RTF)
• 5.4 By Nature
  • 5.4.1 Conventional
  • 5.4.2 Organic
  • 5.4.3 Clean-label/No added sugars & additives
• 5.5 By Distribution Channel
  • 5.5.1 Supermarkets/Hypermarkets
  • 5.5.2 Pharmacies/Medical Stores
  • 5.5.3 Specialty Mom & Baby Stores
  • 5.5.4 Online & Direct-to-Consumer
  • 5.5.5 Convenience & Grocery Stores
• 5.6 By Geography
  • 5.6.1 North America
    • 5.6.1.1 United States
    • 5.6.1.2 Canada
    • 5.6.1.3 Mexico
  • 5.6.2 Europe
    • 5.6.2.1 Germany
    • 5.6.2.2 France
    • 5.6.2.3 United Kingdom
    • 5.6.2.4 Italy
    • 5.6.2.5 Spain
    • 5.6.2.6 Rest of Europe
  • 5.6.3 Asia-Pacific
    • 5.6.3.1 China
    • 5.6.3.2 Japan
    • 5.6.3.3 India
    • 5.6.3.4 South Korea
    • 5.6.3.5 Australia
    • 5.6.3.6 Rest of Asia-Pacific
  • 5.6.4 Middle East & Africa
    • 5.6.4.1 GCC
    • 5.6.4.2 South Africa
    • 5.6.4.3 Rest of Middle East & Africa
  • 5.6.5 South America
    • 5.6.5.1 Brazil
    • 5.6.5.2 Argentina
    • 5.6.5.3 Rest of South America

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products and Services, and Recent Developments)
  • 6.3.1 Abbott Laboratories
  • 6.3.2 Arla Foods amba
  • 6.3.3 Beingmate Baby & Child
  • 6.3.4 Bellamy's Organic
  • 6.3.5 Bobbie
  • 6.3.6 Bubs Australia
  • 6.3.7 ByHeart
  • 6.3.8 China Feihe Ltd.
  • 6.3.9 Danone S.A.
  • 6.3.10 H&H Group (Biostime)
  • 6.3.11 Hero Group (Hero Baby)
  • 6.3.12 HiPP GmbH & Co. Vertrieb KG
  • 6.3.13 Holle baby food AG
  • 6.3.14 Junlebao Dairy
  • 6.3.15 Kendal Nutricare (Kendamil)
  • 6.3.16 Kraft Heinz (Heinz Baby)
  • 6.3.17 Meiji Holdings Co., Ltd.
  • 6.3.18 Morinaga Milk Industry Co., Ltd.
  • 6.3.19 Nestle S.A.
  • 6.3.20 Reckitt
  • 6.3.21 Royal FrieslandCampina N.V. (Friso)
  • 6.3.22 Synutra International
  • 6.3.23 Vinamilk (Dielac)

7 Market Opportunities & Future Outlook

• 7.1 White-space & unmet-need assessment